ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,611.61
      -1.12%
      US Tech 100
      19,005.20
      -1.58%
      Dow Jones
      41,570.01
      -0.65%
      Brent Oil
      70.265
      -0.56%
      Bitcoin
      82,059.24
      -2.38%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Australia
      5. ASX

      6. Avecho Biotechnology Limited (AVE) Quote

      Avecho Biotechnology Limited

      Avecho Biotechnology Limited (AVE)

      AVE SA
      0.006
      0.00
      (0.00%)
      Closed March 18 1:00AM
      Delayed by 20 minutes

      Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

      Premium

      Key stats and details

      Current Price
      0.006
      Bid
      0.005
      Ask
      0.007
      Volume
      0.00
      0.00 Day's Range 0.00
      0.001 52 Week Range 0.009
      Market Cap
      19.016M
      Previous Close
      0.006
      Open
      -
      Last Trade
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      11,819,451
      Shares Outstanding
      3,169,297,013
      Dividend Yield
      -
      PE Ratio
      -10.00
      Earnings Per Share (EPS)
      -0
      Revenue
      2.93M
      Net Profit
      -3.12M

      About Avecho Biotechnology Limited

      Sector
      Pharmaceutical Preparations
      Industry
      Financial Services Div'd
      Website
      www.avecho.com.au
      Headquarters
      Melbourne, Victoria, Aus
      Founded
      1992
      Avecho Biotechnology Limited is listed in the Pharmaceutical Preparations sector of the Australian Stock Exchange with ticker AVE. The last closing price for Avecho Biotechnology was AUD0.01. Over the last year, Avecho Biotechnology shares have traded in a share price range of AUD 0.001 to AUD 0.009.

      Avecho Biotechnology currently has 3,169,297,013 shares outstanding. The market capitalization of Avecho Biotechnology is AUD19.02 million. Avecho Biotechnology has a price to earnings ratio (PE ratio) of -10.00.

      Ask ADVFN Intelligence (AI)

      AVE Latest News

      More News
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.001-14.28571428570.0070.0070.0055124118670.0059015DE
      4000.0060.0090.005219855450.00619131DE
      120.0031000.0030.0090.002118194510.00585309DE
      260.00351400.00250.0090.00177586450.00491216DE
      520.002500.0040.0090.00153133950.00451391DE
      156-0.006-500.0120.0230.00130770770.00551057DE
      2600.0042000.0020.0450.00134342480.0135699DE

      AVE - Frequently Asked Questions (FAQ)

      What is the current Avecho Biotechnology share price?
      The current share price of Avecho Biotechnology is AUD 0.006
      How many Avecho Biotechnology shares are in issue?
      Avecho Biotechnology has 3,169,297,013 shares in issue
      What is the market cap of Avecho Biotechnology?
      The market capitalisation of Avecho Biotechnology is AUD 19.02M
      What is the 1 year trading range for Avecho Biotechnology share price?
      Avecho Biotechnology has traded in the range of AUD 0.001 to AUD 0.009 during the past year
      What is the PE ratio of Avecho Biotechnology?
      The price to earnings ratio of Avecho Biotechnology is -10
      What is the cash to sales ratio of Avecho Biotechnology?
      The cash to sales ratio of Avecho Biotechnology is 11.11
      What is the reporting currency for Avecho Biotechnology?
      Avecho Biotechnology reports financial results in AUD
      What is the latest annual turnover for Avecho Biotechnology?
      The latest annual turnover of Avecho Biotechnology is AUD 2.93M
      What is the latest annual profit for Avecho Biotechnology?
      The latest annual profit of Avecho Biotechnology is AUD -3.12M
      What is the registered address of Avecho Biotechnology?
      The registered address for Avecho Biotechnology is UNIT A8, 2A WESTALL ROAD, CLAYTON, MELBOURNE, VICTORIA, 3168
      What is the Avecho Biotechnology website address?
      The website address for Avecho Biotechnology is www.avecho.com.au
      Which industry sector does Avecho Biotechnology operate in?
      Avecho Biotechnology operates in the FINANCIAL SERVICES DIV'D sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      1ADAdAlta Limited
      AUD 0.008
      (0.00%)
      		0
      14DO1414 Degrees Limited
      AUD 0.008
      (0.00%)
      		0
      14DN1414 Degrees Limited
      AUD 0.00
      (0.00%)
      		0
      14D1414 Degrees Limited
      AUD 0.02
      (0.00%)
      		0
      13S13 Seeds Limited
       0.00
      (0.00%)
      		0
      1ADAdAlta Limited
      AUD 0.008
      (0.00%)
      		0
      14DO1414 Degrees Limited
      AUD 0.008
      (0.00%)
      		0
      14DN1414 Degrees Limited
      AUD 0.00
      (0.00%)
      		0
      14D1414 Degrees Limited
      AUD 0.02
      (0.00%)
      		0
      13S13 Seeds Limited
       0.00
      (0.00%)
      		0
      1ADAdAlta Limited
      AUD 0.008
      (0.00%)
      		0
      14DO1414 Degrees Limited
      AUD 0.008
      (0.00%)
      		0
      14DN1414 Degrees Limited
      AUD 0.00
      (0.00%)
      		0
      14D1414 Degrees Limited
      AUD 0.02
      (0.00%)
      		0
      13S13 Seeds Limited
       0.00
      (0.00%)
      		0

      Discussion

      View Full Feed
      arizona1 arizona1 4 minutes ago
      Internal Social Security Administration Memo surfaces that spells out their "Planned Inefficiency"
      jamess, author

      Under the guise of “preventing fraud,” the Social Security Administration (SSA) is planning to stop phone-line claim services to those who have earned their benefit
      WandererHero90 WandererHero90 4 minutes ago
      That's a crappy thing to say. I think longs come here to speculate, to connect the dots in terms of company statements and industry news, and to share opinions on the latest developments. True longs don't want a phony pump based on lies, they want their investment thesis to come to fruition in a sus
      LWLG
      Rainer Rainer 4 minutes ago
      CATV nice action on news
      10thMountain 10thMountain 5 minutes ago
      But it’s not affecting this stock
      FDCT
      $PennyMover $PennyMover 5 minutes ago
      It hasn't.  I have a photo of almost every week off of otcmarkets 
      GRLF
      PennyMillions852 PennyMillions852 5 minutes ago
      LOL, truly a flipticker....0071 to .0064, happens when a company cant seem to issue any updates and give new eyes a legit reason to buy!
      IGPK
      makinezmoney makinezmoney 6 minutes ago
      $DBGI: Been a winner since Feb..... now $8.75

      Well done...... I used to hold this before the delist


      GO $DBGI
      DBGI
      canadiancrown canadiancrown 6 minutes ago
      Something is coming for sure it was insider buy
      VGLS
      wadegarret wadegarret 6 minutes ago
      Nelson- KINS, thanks

      Yes I found it on the Website. It was $1.5M after tax gain, but they also said it would save them $300K/year in expenses, so more like $1.2M to be taken off the $1.95 guidance, or around $.09. Still $1.86 avg from operations is a 17% increase from last guidanc
      Trooperstocks Trooperstocks 6 minutes ago
      $ILLR #BKFC Fight Night Philly on March 21, 2025, brings high-octane, no-gloves action to fans, continuing BKFC’s momentum as the world’s fastest-growing combat sports promotion. #TrillerGroup #ILLR #BKFC
      https://pbs.twimg.com/media/GlcXLX9XgAAampR?format=jpg&name=medium
      ILLR
      TrendTrade2016 TrendTrade2016 7 minutes ago
      CNSP 4 BUCKS UP STREAM
      CNSP
      lizzy241 lizzy241 7 minutes ago
      Novartis announced layoff's to focus on CVD patients. Someone mentioned they would be a good match for V molecule.
      Ahead of the upcoming loss of patent protection for its best-selling heart failure drug Entresto as well as continued growth of cholesterol medication Leqvio, the company is focu
      AMRN
      mineanddine mineanddine 7 minutes ago
      What about the Tobique?  🤡 
      RONN
      canadiancrown canadiancrown 7 minutes ago
      Alot
      VGLS
      ORCA ORCA 7 minutes ago
      BS.THE 30 DAY IS NOT GOING TO DO A THING.YOU ARE TRYING VERY HARD.GIVE IT UP.YEARLY REPORT IS COMING OUT WE WILL SEE.
      CYBL
      RuudSaltis RuudSaltis 7 minutes ago
      Normal people buy these shares and leave this platform. Why staying here once you found the real answer? Don’t get it.
      LWLG
      Slojab Slojab 7 minutes ago
      Again, it's about context.

      A new NBC News poll shows President Trump with a job approval rating as high as he’s ever had.

      His numbers for DISapproval are still higher than his approval ratings.
      x993231 x993231 7 minutes ago
      OK so yes Homewood Suites by Hilton Denver Tech Center is the place to stay, it is a couple hundred yards from the SHM, I booked a package of 2 non stop flights out of Phila and a room for 2 nights with insurance for less than $650 in total through Expedia.

      X
      LWLG
      Trooperstocks Trooperstocks 7 minutes ago
      $ILLR #BKFC Fight Night Philly on March 21, 2025, brings high-octane, no-gloves action to fans, continuing BKFC’s momentum as the world’s fastest-growing combat sports promotion. #TrillerGroup #ILLR #BKFC
      https://pbs.twimg.com/media/GlcXLX9XgAAampR?format=jpg&name=medium
      ILLR
      EmpressMonk25 EmpressMonk25 8 minutes ago
      Exactly... like show some decency to the champ that made you $14M 😂
      HMBL
      dennisdave dennisdave 8 minutes ago
      Out group is behind you Mike. As soon as your proxy is online we will sign up
      NWBO
      littlejohn littlejohn 8 minutes ago
      We do hope they return safely...

      SMCI getting back testing in the price

      deal lane on Tuesday,

      while biggies are at conference...

      so we watch...LJ
      SMCI
      mineanddine mineanddine 8 minutes ago
      No underlying business, no legitimate operations.  
      IGPK
      BBANBOB BBANBOB 8 minutes ago
      GOODIE

      And different issues within the ""SAME CLASS"" can not be treated differently or prejudicialy

      The company Put out 2 separate 8K and PR stating Prefrd equity interests and COMMON Equity interests
      The two CLASSES ARE COMMON and PREFERED
      COOP

      Your Recent History

      ASX
      AVE
      Avecho Biotechnology
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads